Patricia Taik

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

G. Sonpavde, W. Oh, M. Galsky, 2022, The oncologist.

High genetic diversities between isolates of the fish parasite Cryptocaryon irritans (Ciliophora) suggest multiple cryptic species.

Yen-ling Song, Wei-Jen Chang, H. Gong, 2017, Molecular phylogenetics and evolution.

USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors.

M. Mahajan, R. Sebra, Rong Chen, 2020, The Journal of clinical endocrinology and metabolism.

Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

P. Schirmacher, S. Friedman, P. Boffetta, 2021, Journal of hepatology.

Parafibromin Abnormalities in Ossifying Fibroma

R. Sebra, Rong Chen, A. Uzilov, 2021, Journal of the Endocrine Society.

A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer

E. Schadt, Yevgeniy Antipin, R. Sebra, 2019, Science Advances.

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

V. Mazzaferro, S. Friedman, J. Llovet, 2022, Gut.

A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma

E. Schadt, Yevgeniy Antipin, R. Sebra, 2021, iScience.